Vizient advocacy letters and Congressional statements

With direct letters, regulatory comments and other activities, Vizient strives to form constructive relationships with lawmakers, regulatory agencies and administration officials, to provide a unified voice on issues that have a direct impact on our members.

2025 Advocacy

August 12 – Vizient endorses the Protecting Health Care and Lowering Costs Act

August 6 - Vizient endorses the Protect Medicaid and Rural Hospitals Act

July 29 – Vizient endorses the Resident Physician Shortage Reduction Act of 2025

July 29 – Vizient endorses the Biosimilar Red Tape Elimination Act

July 15 – Vizient endorses the Mapping America's Pharmaceutical Supply (MAPS) Act

July 14 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on Implementation of Prior Authorization for Select Services under the Wasteful and Inappropriate Services Reduction (WISeR) Model

July 14 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Preserving Medicaid Funding for Vulnerable Populations — Closing a Health Care-Related Tax Loophole proposed rule

July 2 – Vizient responds to the Centers for Medicare and Medicaid Services (CMS) Hospital Price Transparency Accuracy and Completeness Request for Information (RFI)

June 27 – Vizient submits comments to the Agency for Healthcare Research and Quality (AHRQ) on Opportunities to Update the Patient Safety Indicators (PSIs)

June 26 - Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Medicare Drug Price Negotiation Program (MDPNP) Draft Guidance

June 10 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the fiscal year (FY) 2026 Hospital Inpatient Prospective Payment System (IPPS) proposed rule

May 30 - Vizient expresses support for increasing funding for Children's Graduate Medical Education in FY 2026 to $778 million

May 27 - Vizient endorses the Save Healthcare Workers Act

May 8 - Vizient endorses legislation to lower prescription drugs costs and increase access to generics and biosimilars

May 7 – Vizient comments to the Department of Commerce regarding the imports of pharmaceuticals and pharmaceutical ingredients and their derivative products

April 14 - Vizient comments to the Assistant Secretary for Technology Policy (ASTP) on the United States Core Data for Interoperability (USCDI) Draft Version 6

March 18 – Vizient comments to the Drug Enforcement Administration (DEA) on the Special Registrations for Telemedicine and Limited State Telemedicine Regulations proposed rule

March 7 – Vizient comments to the HHS Office of Civil Rights on the proposed Health Insurance Portability and Accountability Act (HIPAA) Security Rule to Strengthen the Cybersecurity of Electronic Protected Health Information (ePHI)

March 4 - Vizient letter to the President and Secretary of Homeland Security regarding recently enacted tariffs on products imported from Canada, Mexico and China

February 24 - Vizient letter to congressional leadership urging permanent or long-term access to telehealth services

February 4 - Vizient letter to the President and Secretary of Homeland Security regarding recently announced tariffs on products imported from Canada, Mexico and China

January 27 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program proposed rule

Connect with Vizient to help you solve health care’s biggest challenges